Health‐Related Quality of Life and Cognitive Functioning in Pediatric Liver Transplant Recipients

Daniella Ohnemus, Katie Neighbors, Karen Rychlik, Robert S. Venick, John C. Bucuvalas, Shikha S. Sundaram, Vicky L. Ng, Walter S. Andrews, Yumi Turmelle, George V. Mazariegos, Lisa G. Sorensen, Estella M. Alonso, for Studies of Pediatric Liver Transplantation (SPLIT) – 11 September 2019 – The goal of this work was to examine the change in health‐related quality of life (HRQOL) and cognitive functioning from early childhood to adolescence in pediatric liver transplantation (LT) recipients.

PDLIM1 Inhibits Tumor Metastasis Through Activating Hippo Signaling in Hepatocellular Carcinoma

Zhao Huang, Jian‐Kang Zhou, Kui Wang, Haining Chen, Siyuan Qin, Jiayang Liu, Maochao Luo, Yan Chen, Jingwen Jiang, Li Zhou, Lei Zhu, Juan He, Jiao Li, Wenchen Pu, Yanqiu Gong, Jianbo Li, Qin Ye, Dandan Dong, Hongbo Hu, Zongguang Zhou, Lunzhi Dai, Canhua Huang, Xiawei Wei, Yong Peng – 11 September 2019

LiverLearning®: 2019 Webinar: HCC Staging and Treatments

This webinar will cover Barcelona Clinic Liver Cancer (BCLC) staging in hepatocellular carcinoma. Attendees will also receive an overview of curative options of surgical resection, liver transplant, and ablative techniques and noncurative options of TACE, TARE, SBRT, and systemic chemotherapy. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .Vicki Shah Vicki Shah PA-C, MMS received a Bachelor’s of Science in Biochemistry with minor in Mathematics from California State University, Long Beach.

Monoacylglycerol Lipase Inhibition Protects From Liver Injury in Mouse Models of Sclerosing Cholangitis

Matteo Tardelli, Francesca V. Bruschi, Claudia D. Fuchs, Thierry Claudel, Nicole Auer, Victoria Kunczer, Maximilian Baumgartner, Onne A.H.O. Ronda, Henk Jan Verkade, Tatjana Stojakovic, Hubert Scharnagl, Aida Habib, Robert Zimmermann, Sophie Lotersztajn, Michael Trauner – 10 September 2019

Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis

Meghan Mooring, Brendan H. Fowl, Shelly Z.C. Lum, Ye Liu, Kangning Yao, Samir Softic, Rory Kirchner, Aaron Bernstein, Aatur D. Singhi, Daniel G. Jay, C. Ronald Kahn, Fernando D. Camargo, Dean Yimlamai – 10 September 2019

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis

Elliot B. Tapper, James B. Henderson, Neehar D. Parikh, George N. Ioannou, Anna S. Lok – 6 September 2019 – Hepatic encephalopathy (HE) is a devastating complication of cirrhosis. Data are limited regarding the incidence of and risk factors for HE among contemporary patients in the context of the shifting epidemiology of cirrhosis. We examined a 20% random sample of U.S. Medicare enrollees with cirrhosis and Part D prescription coverage from 2008 to 2014. We modelled incident HE using demographic, clinical, and pharmacologic data.

Subscribe to